新加坡 NUHS授予US $25米补助领导关于消除乙肝研究

StephenW

      
        


                    

• Singapore
  

NUHS awarded S$25m grant to lead studies on eradicating Hepatitis B      
   
            The researchers aim to discover new drug targets and develop new treatments to cure Hepatitis B.   

•       By         Lee Li Ying, Channel NewsAsia
• Posted 23 May 2016 16:01
• Updated 23 May 2016 19:50
  

        

• PHOTOS
  

                                                            File photo of a nurse preparing an injection. (AFP/Nicolas Asfouri)      
   
  
  
      SINGAPORE: The National University Health System (NUHS) has been awarded S$25 million to lead research studies on eradicating Hepatitis B, it announced in a press release on May 23 (Monday).
A total of 29 researchers and scientists from NUHS, Agency for Science, Technology and Research (A*STAR), National University of Singapore, DUKE-NUS Graduate Medical School, Singapore General Hospital, Tan Tock Seng Hospital and Changi General Hospital are involved.

There are 17 research studies under this grant and researchers aim to discover new drug targets and develop new treatments to cure Hepatitis B over a five-year period.
In Singapore, an estimated 3.6 per cent of the population have Hepatitis B, and it is the most common cause of liver cirrhosis and liver cancer in the city-state. Studies have shown that 45 per cent of people afflicted with Hepatitis B are cured naturally of the disease as their immune systems get rid of the virus over a period of at least 25 years.

The other 55 per cent of the population may have to be on long-term medication. Overall, about 20 per cent to 30 per cent of them also have a possibility of developing further complications which may eventually lead to liver failure.
Said Professor Lim Seng Gee, the programme lead of the research studies: “Unlike other chronic diseases such as hypertension and diabetes, chronic Hepatitis B can be cured. Up to now, however, there has been no comprehensive strategy or approach towards achieving a cure. With the help of patients, our hepatologist experts, unique laboratory research models, and the state-of-the-art technology, we are now definitively poised to tackle the Hepatitis B virus in Singapore, and potentially eliminate it.”


   

- CNA/dl

StephenW

新加坡

NUHS授予US $25米补助领导关于消除乙肝研究
研究人员的目标是发现新的药物靶点，开发新的治疗方法治愈乙型肝炎

    李李瑛，亚洲新闻频道
    发表于2016年5月23日16:01更新23 19:50 2016年5月

    相片

护士准备注射的档案照片。 （AFP /萨科Asfouri）



新加坡：国立大学健康系统（NUHS）已获得US $ 2500万带领根除乙肝的调查研究，在其5月23日（星期一）一份新闻稿中宣布。

共有29个研究人员和科学家从NUHS，局科学技术研究局（A * STAR），新加坡国立大学，杜克 - 新加坡国立大学医学研究生院，新加坡中央医院，陈笃生医院和樟宜综合医院都有涉及。

有17这笔款项下的调查研究和研究人员的目标是发现新的药物靶点，开发新的治疗方法在5年的时间内治愈乙肝。

在新加坡，人口估计有3.6％的人有乙肝，是肝硬化和肝癌的城邦最常见的原因。有研究表明，人乙型肝炎折磨45％的自然治愈疾病的是他们的免疫系统得到了一个为期至少25年的清除病毒。

人口的其他55％的可能要长期服药。总体而言，约20％至30％的人也有制定进一步的并发症可能最终导致肝功能衰竭的可能性。

教授说，林生啧啧，该研究报告的项目首席：“不像其他慢性疾病，如高血压，糖尿病，慢性乙肝是可以治愈的。截至目前，然而，有已经实现治愈没有全面的战略或方式。随着患者，我们的专家肝病，独特的实验室研究模型的帮助下，和国家的最先进的技术，我们现在明确准备应对乙肝病毒在新加坡，并有可能消除它。“

- CNA /分升